Related references
Note: Only part of the references are listed.B cells are associated with survival and immunotherapy response in sarcoma
Florent Petitprez et al.
NATURE (2020)
Tertiary lymphoid structures improve immunotherapy and survival in melanoma
Rita Cabrita et al.
NATURE (2020)
B cells and tertiary lymphoid structures promote immunotherapy response
Beth A. Helmink et al.
NATURE (2020)
Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours
Devalingam Mahalingam et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2020)
Exploiting Human NK Cells in Tumor Therapy
Paola Vacca et al.
FRONTIERS IN IMMUNOLOGY (2020)
BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial
Bruno Bockorny et al.
NATURE MEDICINE (2020)
Lenalidomide and pomalidomide potently interfere with induction of myeloid-derived suppressor cells in multiple myeloma
Saeko Kuwahara-Ota et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Glioblastoma Myeloid-Derived Suppressor Cell Subsets Express Differential Macrophage Migration Inhibitory Factor Receptor Profiles That Can Be Targeted to Reduce Immune Suppression
Tyler J. Alban et al.
FRONTIERS IN IMMUNOLOGY (2020)
Prognostic significance of macrophage migration inhibitory factor expression in cancer patients A systematic review and meta-analysis
Hyun Min Koh et al.
MEDICINE (2020)
Evaluating macrophage migration inhibitory factor 1 expression as a prognostic biomarker in colon cancer
Lina Olsson et al.
TUMOR BIOLOGY (2020)
A guide to cancer immunotherapy: from T cell basic science to clinical practice
Alex D. Waldman et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Dendritic cells in cancer immunology and immunotherapy
Stefanie K. Wculek et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Neutrophil plasticity in the tumor microenvironment
Morgan A. Giese et al.
BLOOD (2019)
Macrophage migration inhibitory factor regulates innate γδ T-cell responses via IL-17 expression
Hee Kyung Kim et al.
FASEB JOURNAL (2019)
Antigen delivery targeted to tumor-associated macrophages overcomes tumor immune resistance
Daisuke Muraoka et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Regulatory T cells in cancer immunosuppression - implications for anticancer therapy
Yosuke Togashi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Evolving complexity of MIF signaling
Stanislovas S. Jankauskas et al.
CELLULAR SIGNALLING (2019)
Circulating soluble levels of MIF in women with breast cancer in the molecular subtypes: relationship with Th17 cytokine profile
Guadalupe Avalos-Navarro et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2019)
The IL-17 Family of Cytokines in Health and Disease
Mandy J. McGeachy et al.
IMMUNITY (2019)
CXCR2 expression on granulocyte and macrophage progenitors under tumor conditions contributes to mo-MDSC generation via SAP18/ERK/STAT3
Xiaoqing Han et al.
CELL DEATH & DISEASE (2019)
Phase I/II trial of the CXCR4 inhibitor plerixafor in combination with bortezomib as a chemosensitization strategy in relapsed/refractory multiple myeloma
Irene M. Ghobrial et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Functional MIF promoter haplotypes modulate Th17-related cytokine expression in peripheral blood mononuclear cells from control subjects and rheumatoid arthritis patients
Luis Alexis Hernandez-Palma et al.
CYTOKINE (2019)
MDSC; the Most Important Cell You Have Never Heard Of
R. J. Tesi
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Role of Matrix Metalloproteinases in Angiogenesis and Cancer
Saray Quintero-Fabian et al.
FRONTIERS IN ONCOLOGY (2019)
Chemokines Modulate Immune Surveillance in Tumorigenesis, Metastasis, and Response to Immunotherapy
Anna E. Vilgelm et al.
FRONTIERS IN IMMUNOLOGY (2019)
Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression
Heng Lin et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Advances and Insights for Small Molecule Inhibition of Macrophage Migration Inhibitory Factor
Vinay Trivedi-Parmar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Macrophage Migration Inhibitory Factor protects cancer cells from immunogenic cell death and impairs anti-tumor immune responses
Kristen N. Balogh et al.
PLOS ONE (2018)
Oral squamous carcinoma cells promote macrophage polarization in an MIF-dependent manner
M. Barbosa de Souza Rizzo et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2018)
Chemokine CCL4 Induces Vascular Endothelial Growth Factor C Expression and Lymphangiogenesis by miR-195-3p in Oral Squamous Cell Carcinoma
Ming-Yu Lien et al.
FRONTIERS IN IMMUNOLOGY (2018)
Blockade of MIF-CD74 Signalling on Macrophages and Dendritic Cells Restores the Antitumour Immune Response Against Metastatic Melanoma
Carlos R. Figueiredo et al.
FRONTIERS IN IMMUNOLOGY (2018)
The macrophage migration inhibitory factor pathway in human B cells is tightly controlled and dysregulated in multiple sclerosis
Liza Rijvers et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2018)
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors
Sahil Gupta et al.
ONCOIMMUNOLOGY (2018)
Roles of the immune system in cancer: from tumor initiation to metastatic progression
Hugo Gonzalez et al.
GENES & DEVELOPMENT (2018)
Macrophage Migration Inhibitory Factor (MIF) Drives Murine Psoriasiform Dermatitis
Siegfried Bezdek et al.
FRONTIERS IN IMMUNOLOGY (2018)
CD4+ T cell help in cancer immunology and immunotherapy
Jannie Borst et al.
NATURE REVIEWS IMMUNOLOGY (2018)
A phase I-II clinical trial of the anti-CD74 monoclonal antibody milatuzumab in frail patients with refractory chronic lymphocytic leukaemia: A patient based approach
Michal Haran et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
CXCL2/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer
H. Zhang et al.
ONCOGENE (2017)
Targeting of interleukin (IL)-17A inhibits PDL1 expression in tumor cells and induces anticancer immunity in an estrogen receptor-negative murine model of breast cancer
Yun-Feng Ma et al.
ONCOTARGET (2017)
The AP-1 Transcription Factor c-Jun Promotes Arthritis by Regulating Cyclooxygenase-2 and Arginase-1 Expression in Macrophages
Nicole Hannemann et al.
JOURNAL OF IMMUNOLOGY (2017)
Myeloid-derived suppressor cellsa new therapeutic target to overcome resistance to cancer immunotherapy
Jason A. Chesney et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2017)
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
Sydney R. Gordon et al.
NATURE (2017)
Tumour-associated macrophages as treatment targets in oncology
Alberto Mantovani et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Metabolic origins of spatial organization in the tumor microenvironment
Carlos Carmona-Fontaine et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
JunB promotes Th17 cell identity and restrains alternative CD4+ T-cell programs during inflammation
Tiffany M. Carr et al.
NATURE COMMUNICATIONS (2017)
Tumour and host cell PD-L1 is required to mediate suppression of anti-tumour immunity in mice
Janet Lau et al.
NATURE COMMUNICATIONS (2017)
Myeloid-Derived Suppressor Cells
Dmitry I. Gabrilovich
CANCER IMMUNOLOGY RESEARCH (2017)
γδ T Cells: Unexpected Regulators of Cancer Development and Progression
Christopher Fleming et al.
TRENDS IN CANCER (2017)
MIF Is Necessary for Late-Stage Melanoma Patient MDSC Immune Suppression and Differentiation
Kavitha Yaddanapudi et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Macrophage migration inhibitory factor (MIF) is induced by cytotoxic drugs and is involved in immune escape and migration in childhood rhabdomyosarcoma
Sarah Maria Johler et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
γδ T Cells Support Pancreatic Oncogenesis by Restraining αβ T Cell Activation
Donnele Daley et al.
CELL (2016)
The urgent need to recover MHC class I in cancers for effective immunotherapy
Federico Garrido et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
CD45 Phosphatase Inhibits STAT3 Transcription Factor Activity in Myeloid Cells and Promotes Tumor-Associated Macrophage Differentiation
Vinit Kumar et al.
IMMUNITY (2016)
Deletion of macrophage migration inhibitory factor inhibits murine oral carcinogenesis: Potential role for chronic pro-inflammatory immune mediators
Steve Oghumu et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Macrophage migration inhibitory factor enhances autophagy by regulating ROCK1 activity and contributes to the escape of dendritic cell surveillance in glioblastoma
Shugang Xu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
The impact of hypoxia on tumor-associated macrophages
Anne-Theres Henze et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer
Kipp Weiskopf et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Expression of MIF and c-erbB-2 in endometrial cancer
Wei Xiao et al.
MOLECULAR MEDICINE REPORTS (2016)
Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion
Balint Otvos et al.
STEM CELLS (2016)
NK cells and cancer: you can teach innate cells new tricks
Maelig G. Morvan et al.
NATURE REVIEWS CANCER (2016)
MIF inhibition reverts the gene expression profile of human melanoma cell line-induced MDSCs to normal monocytes
Sabine Waigel et al.
GENOMICS DATA (2016)
MIF interacts with CXCR7 to promote receptor internalization, ERK1/2 and ZAP-70 signaling, and lymphocyte chemotaxis
Setareh Alampour-Rajabi et al.
FASEB JOURNAL (2015)
Macrophage Migration Inhibitory Factor Interacting with Th17 Cells May Be Involved in the Pathogenesis of Autoimmune Damage in Hashimoto's Thyroiditis
Haibo Xue et al.
MEDIATORS OF INFLAMMATION (2015)
The IL-23-IL-17 axis in inflammatory arthritis
Erik Lubberts
NATURE REVIEWS RHEUMATOLOGY (2015)
Cross-presentation of cell-associated antigens by MHC class I in dendritic cell subsets
Enric Gutierrez-Martinez et al.
FRONTIERS IN IMMUNOLOGY (2015)
IL-17A Produced by γδ T Cells Promotes Tumor Growth in Hepatocellular Carcinoma
Shoubao Ma et al.
CANCER RESEARCH (2014)
Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines
Peter J. Murray et al.
IMMUNITY (2014)
HIF Transcription Factors, Inflammation, and Immunity
Asis Palazon et al.
IMMUNITY (2014)
HLA-DRα1 Constructs Block CD74 Expression and MIF Effects in Experimental Autoimmune Encephalomyelitis
Roberto Meza-Romero et al.
JOURNAL OF IMMUNOLOGY (2014)
Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
Oscar R. Colegio et al.
NATURE (2014)
Murine CD27(-) Vγ6(+) γδ T cells producing IL-17A promote ovarian cancer growth via mobilization of protumor small peritoneal macrophages
Margarida Rei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
T helper 17 cells play a critical pathogenic role in lung cancer
Seon Hee Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The cellular and molecular origin of tumor-associated macrophages
Ruth A. Franklin et al.
SCIENCE (2014)
β-Catenin Promotes Colitis and Colon Cancer Through Imprinting of Proinflammatory Properties in T Cells
Shilpa Keerthivasan et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Th17 cellsin cancer: the ultimate identity crisis
Stefanie R. Bailey et al.
FRONTIERS IN IMMUNOLOGY (2014)
Phase I, multicentre, dose-escalation trial of monotherapy with milatuzumab (humanized anti-CD74 monoclonal antibody) in relapsed or refractory multiple myeloma
Jonathan L. Kaufman et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
CXCR2-Expressing Myeloid-Derived Suppressor Cells Are Essential to Promote Colitis-Associated Tumorigenesis
Hiroshi Katoh et al.
CANCER CELL (2013)
Impeding Macrophage Entry into Hypoxic Tumor Areas by Sema3A/Nrp1 Signaling Blockade Inhibits Angiogenesis and Restores Antitumor Immunity
Andrea Casazza et al.
CANCER CELL (2013)
Control of Tumor-Associated Macrophage Alternative Activation by Macrophage Migration Inhibitory Factor
Kavitha Yaddanapudi et al.
JOURNAL OF IMMUNOLOGY (2013)
Cytokine patterns in patients with cancer: a systematic review
Bodo E. Lippitz
LANCET ONCOLOGY (2013)
Succinate is an inflammatory signal that induces IL-1β through HIF-1α
G. M. Tannahill et al.
NATURE (2013)
Capillary and arteriolar pericytes attract innate leukocytes exiting through venules and 'instruct' them with pattern-recognition and motility programs
Konstantin Stark et al.
NATURE IMMUNOLOGY (2013)
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
Stephanie M. Pyonteck et al.
NATURE MEDICINE (2013)
The vascular biology of macrophage migration inhibitory factor (MIF) Expression and effects in inflammation, atherogenesis and angiogenesis
Yaw Asare et al.
THROMBOSIS AND HAEMOSTASIS (2013)
MIF Produced by Bone Marrow-Derived Macrophages Contributes to Teratoma Progression after Embryonic Stem Cell Transplantation
Xi Wang et al.
CANCER RESEARCH (2012)
D-dopachrome tautomerase (D-DT or MIF-2): Doubling the MIF cytokine family
Melanie Merk et al.
CYTOKINE (2012)
Stat3 and Gfi-1 Transcription Factors Control Th17 Cell Immunosuppressive Activity via the Regulation of Ectonucleotidase Expression
Fanny Chalmin et al.
IMMUNITY (2012)
Tumor Microenvironment Macrophage Inhibitory Factor Directs the Accumulation of Interleukin-17-producing Tumor-infiltrating Lymphocytes and Predicts Favorable Survival in Nasopharyngeal Carcinoma Patients
Jiang Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Negative Regulation of AMP-activated Protein Kinase (AMPK) Activity by Macrophage Migration Inhibitory Factor (MIF) Family Members in Non-small Cell Lung Carcinomas
Stephanie E. Brock et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Role of Macrophage Migration Inhibitory Factor in the Regulatory T Cell Response of Tumor-Bearing Mice
Susanna Choi et al.
JOURNAL OF IMMUNOLOGY (2012)
Macrophage Migration Inhibitory Factor Promotes Tumor Growth and Metastasis by Inducing Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Kendra D. Simpson et al.
JOURNAL OF IMMUNOLOGY (2012)
Origins of tumor-associated macrophages and neutrophils
Virna Cortez-Retamozo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Differentiation of human peripheral blood Vδ1+ T cells expressing the natural cytotoxicity receptor NKp30 for recognition of lymphoid leukemia cells
Daniel V. Correia et al.
BLOOD (2011)
PGE2-Induced CXCL12 Production and CXCR4 Expression Controls the Accumulation of Human MDSCs in Ovarian Cancer Environment
Natasa Obermajer et al.
CANCER RESEARCH (2011)
Activation of the JNK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on CXCR4 and CD74
Hongqi Lue et al.
CELLULAR SIGNALLING (2011)
Validity of plasma macrophage migration inhibitory factor for diagnosis and prognosis of hepatocellular carcinoma
Yi-Ming Zhao et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Tumor-derived macrophage migration inhibitory factor modulates the biology of head and neck cancer cells via neutrophil activation
Claudia A. Dumitru et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors
Sid P. Kerkar et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Uncovering the Role of Invariant Chain in Controlling MHC Class II Antigen Capture
Ronald N. Germain
JOURNAL OF IMMUNOLOGY (2011)
The secret second life of an innocent chaperone: the story of CD74 and B cell/chronic lymphocytic leukemia cell survival
Idit Shachar et al.
LEUKEMIA & LYMPHOMA (2011)
β-Arrestin1 Mediates the Endocytosis and Functions of Macrophage Migration Inhibitory Factor
Lishi Xie et al.
PLOS ONE (2011)
The D-dopachrome tautomerase (DDT) gene product is a cytokine and functional homolog of macrophage migration inhibitory factor (MIF)
Melanie Merk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma
Mark P. Chao et al.
CELL (2010)
Macrophage Diversity Enhances Tumor Progression and Metastasis
Bin-Zhi Qian et al.
CELL (2010)
Tumor-infiltrating IL-17-producing γδ T cells support the progression of tumor by promoting angiogenesis
Daiko Wakita et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion
Vasilena Gocheva et al.
GENES & DEVELOPMENT (2010)
TAp63 Regulates VLA-4 Expression and Chronic Lymphocytic Leukemia Cell Migration to the Bone Marrow in a CD74-Dependent Manner
Inbal Binsky et al.
JOURNAL OF IMMUNOLOGY (2010)
Macrophage Migration Inhibitory Factor Is Secreted by Rhabdomyosarcoma Cells, Modulates Tumor Metastasis by Binding to CXCR4 and CXCR7 Receptors and Inhibits Recruitment of Cancer-Associated Fibroblasts
Maciej Tarnowski et al.
MOLECULAR CANCER RESEARCH (2010)
The MIF Homologue D-Dopachrome Tautomerase Promotes COX-2 Expression through β-Catenin-Dependent and -Independent Mechanisms
Dan Xin et al.
MOLECULAR CANCER RESEARCH (2010)
Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast
Yoonsang Cho et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
T(H)17 cells in tumour immunity and immunotherapy
Weiping Zou et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Endogenous IL-17 contributes to reduced tumor growth and metastasis
Ilona Kryczek et al.
BLOOD (2009)
Macrophage migration inhibitory factor (MIF) plays a critical role in pathogenesis of ultraviolet-B (UVB) -induced nonmelanoma skin cancer (NMSC)
Jason Martin et al.
FASEB JOURNAL (2009)
T Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor Immunity
Natalia Martin-Orozco et al.
IMMUNITY (2009)
Macrophage migration inhibitory factor stimulates interleukin-17 expression and production in lymph node cells
Ivana Stojanovic et al.
IMMUNOLOGY (2009)
Discovery of Human Macrophage Migration Inhibitory Factor (MIF)-CD74 Antagonists via Virtual Screening
Zoe Cournia et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
A Tautomerase-Null Macrophage Migration-Inhibitory Factor (MIF) Gene Knock-In Mouse Model Reveals That Protein Interactions and Not Enzymatic Activity Mediate MIF-Dependent Growth Regulation
Guenter Fingerle-Rowson et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β-dependent adaptive immunity against tumors
Francois Ghiringhelli et al.
NATURE MEDICINE (2009)
A novel, macrophage migration inhibitory factor suicide substrate inhibits motility and growth of lung cancer cells
Millicent Winner et al.
CANCER RESEARCH (2008)
Hypoxia-inducible factor augments experimental colitis through an MIF-dependent inflammatory signaling cascade
Yatrik M. Shah et al.
GASTROENTEROLOGY (2008)
Cooperative regulation of non-small cell lung carcinoma angiogenic potential by macrophage migration inhibitory factor and its homolog, D-dopachrome tautomerase
Arlixer M. Coleman et al.
JOURNAL OF IMMUNOLOGY (2008)
Expression of macrophage migration inhibitory factor by neuroblastoma leads to the inhibition of antitumor T cell reactivity in vivo
Qiang Zhou et al.
JOURNAL OF IMMUNOLOGY (2008)
Macrophage migration inhibitory factor contributes to the immune escape of ovarian cancer by down-regulating NKG2D
Mathias Krockenberger et al.
JOURNAL OF IMMUNOLOGY (2008)
Role of MIF in Inflammation and Tumorigenesis
Jan-Philipp Bach et al.
ONCOLOGY (2008)
Macrophage migration inhibitory factor has a MHC class I-like motif and function
D. J. Gibbings et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2008)
CTLA-4 control over Foxp3+ regulatory T cell function
Kajsa Wing et al.
SCIENCE (2008)
The role of myeloid cells in the promotion of tumour angiogenesis
Craig Murdoch et al.
NATURE REVIEWS CANCER (2008)
The inhibitory cytokine IL-35 contributes to regulatory T-cell function
Lauren W. Collison et al.
NATURE (2007)
IL-8 secreted in a macrophage migration-inhibitory factor- and CD74-dependent manner regulates B cell chronic lymphocytic leukemia survival
Inbal Binsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
Silvia Deaglio et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment
Juergen Bernhagen et al.
NATURE MEDICINE (2007)
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer
Junzo Hamanishi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Impaired DNA damage checkpoint response in MIF-deficient mice
Alice Nemajerova et al.
EMBO JOURNAL (2007)
Amplification of tumor hypoxic responses by macrophage migration inhibitory factor-dependent hypoxia-inducible factor stabilization
Millicent Winner et al.
CANCER RESEARCH (2007)
Monocyte/macrophage infiltration in tumors: modulators of angiogenesis
Anita E. M. Dirkx et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex
Xuerong Shi et al.
IMMUNITY (2006)
Dual regulation of macrophage migration inhibitory factor (MIF) expression in hypoxia by CREB and HIF-1
John A. Baugh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Suppression of antitumor immunity by IL-10 and TGF-β-producing T cells infiltrating the growing tumor:: Influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells
Andrew G. Jarnicki et al.
JOURNAL OF IMMUNOLOGY (2006)
Cutting edge: Induction of B7-H4 on APCs through IL-10: Novel suppressive mode for regulatory T cells
Ilona Kryczek et al.
JOURNAL OF IMMUNOLOGY (2006)
MIF:: a new cytokine link between rheumatoid arthritis and atherosclerosis
EF Morand et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Regulatory T cells, tumour immunity and immunotherapy
WP Zou
NATURE REVIEWS IMMUNOLOGY (2006)
Tumor-derived macrophage migration inhibitory factor (MIF) inhibits T lymphocyte activation
Xiaocai Yan et al.
CYTOKINE (2006)
Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor
TRDJ Radstake et al.
ARTHRITIS AND RHEUMATISM (2005)
Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: A mechanism of tumor evasion
AH Zea et al.
CANCER RESEARCH (2005)
Binding of JAB1/CSN5 to MIF is mediated by the MPN domain but is in dependent of the JAMM motif
A Burger-Kentischer et al.
FEBS LETTERS (2005)
Distinct aerobic and hypoxic mechanisms of HIF-α regulation by CSN5
L Bemis et al.
GENES & DEVELOPMENT (2004)
Human T regulatory cells can use the perforin pathway to cause autologous target cell death
WJ Grossman et al.
IMMUNITY (2004)
Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses
PC Rodriguez et al.
CANCER RESEARCH (2004)
Macrophage migration inhibitory factor: A regulator of innate immunity
T Calandra et al.
NATURE REVIEWS IMMUNOLOGY (2003)
COP9 signalosome: A multifunctional regulator of SCF and other cullin-based ubiquitin Ligases
GA Cope et al.
CELL (2003)
Regulated secretion of macrophage migration inhibitory factor is mediated by a non-classical pathway involving an ABC transporter
O Flieger et al.
FEBS LETTERS (2003)
γδ T cells provide an early source of interferon γ in tumor immunity
YF Gao et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
L-arginine consumption by macrophages modulates the expression of CD3ξ chain in T lymphocytes
PC Rodriguez et al.
JOURNAL OF IMMUNOLOGY (2003)
MIF signal transduction initiated by binding to CD74
L Leng et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Interleukin-17 promotes angiogenesis and tumor growth
M Numasaki et al.
BLOOD (2003)
Contribution of macrophage migration inhibitory factor to extracellular signal-regulated kinase activation by oxidative stress in cardiomyocytes
J Fukuzawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: Regulatory role in the innate immune response
RA Mitchell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Receptor binding and cellular uptake studies of macrophage migration inhibitory factor (MIF): Use of biologically active labeled MIF derivatives
R Kleemann et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2002)
Regulation of cutaneous malignancy by γδ T cells
M Girardi et al.
SCIENCE (2001)
Non-small cell lung cancer cells induce monocytes to increase expression of angiogenic activity
ES White et al.
JOURNAL OF IMMUNOLOGY (2001)
CD47-signal regulatory protein α (SIRPα) regulates Fcγ and complement receptor-mediated phagocytosis
PA Oldenborg et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy
EY Lin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Regulation of the CTL response by macrophage migration inhibitory factor
R Abe et al.
JOURNAL OF IMMUNOLOGY (2001)
Posttranslational modification of the glycosylation inhibiting factor (GIF) gene product generates bioactive GIF
H Watarai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1
R Kleemann et al.
NATURE (2000)
Human uveal melanoma cells produce macrophage migration-inhibitory factor to prevent lysis by NK cells
AC Repp et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
